BIOFILCHEM — Biofil Chemicals and Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Market Cap
IN₹1.10bn
Enterprise Value
IN₹1.11bn
Revenue
IN₹300.35m

Annual balance sheet for Biofil Chemicals and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1.36	2.56	4.41	1.45	0.377
Net Total Accounts Receivable
Net Total Receivables	120	297	172	71.7	205
Total Inventory
Total Other Current Assets
Total Current Assets	139	323	235	93.1	224
Net Property, Plant And Equipment	103	101	97.8	94.2	90
Other Long Term Assets
Total Assets	242	424	332	187	314
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	106	275	168	14.9	137
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	106	275	171	18.9	141
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	136	149	161	168	173
Total Liabilities & Shareholders' Equity	242	424	332	187	314
Total Common Shares Outstanding